Testicular cancer survivors may have hearing loss after cisplatin therapy, study shows

Many testicular cancer survivors experience hearing loss after cisplatin-based chemotherapy, according to researchers who studied, for the first time, the cumulative effects of cisplatin-based chemotherapy on hearing levels in testicular cancer survivors through comprehensive audiometry measurements. They found that increasing doses of cisplatin were associated with increased hearing loss at most of the tested frequencies, involving 4, 6, 8, 10, and 12 kHz.